Artificial intelligence-assisted invasion risk scoring in tru-cut biopsies of ductal carcinoma in situ; predictive role of estrogen receptor and her2 expression
Turkish Journal of Pathology · 2025
DOI: 10.5146/tjpath.2026.14901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Pathology, 2025. Verfasst von Evren Uzun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Gaziantep University Hospital, GAZİANTEP, TÜRKİYE. Hauptthemen laut MEDLINE: Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms, Biomarkers, Tumor, Generative Artificial Intelligence. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Gaziantep University Hospital, GAZİANTEP, TÜRKİYE.
- Department of Pathology, Şanl�±urfa Education and Research Hospital, ŞANLIURFA, TÜRKİYE.
Zitieren
APA
Uzun, E., & Bulut, K. (2025). Artificial intelligence-assisted invasion risk scoring in tru-cut biopsies of ductal carcinoma in situ; predictive role of estrogen receptor and her2 expression. Turkish Journal of Pathology. https://doi.org/10.5146/tjpath.2026.14901
Vancouver
Uzun E, Bulut K. Artificial intelligence-assisted invasion risk scoring in tru-cut biopsies of ductal carcinoma in situ; predictive role of estrogen receptor and her2 expression. Turkish Journal of Pathology. 2025. doi:10.5146/tjpath.2026.14901
BibTeX
@article{Uzun2025,
author = {Uzun, Evren and Bulut, Kubra},
title = {Artificial intelligence-assisted invasion risk scoring in tru-cut biopsies of ductal carcinoma in situ; predictive role of estrogen receptor and her2 expression},
journal = {Turkish Journal of Pathology},
year = {2025},
doi = {10.5146/tjpath.2026.14901}
}
EUVIMED